Trump’s pharmaceutical tariff threat loses bite after Pfizer deal reassures...
Pfizer's $70 billion U.S. investment deal exempts it from tariffs, boosting drugmaker stocks.
Pfizer's $70 billion U.S. investment deal exempts it from tariffs, boosting drugmaker stocks.
Trump's deal with Pfizer exempts it from tariffs, boosting drugmaker stocks.
U.S. tariffs now exceed 17%, the highest since 1935, causing confusion among CEOs.
Nvidia and AMD can sell chips to China, paying 15% of revenues to the U.S. government.
Business leaders face challenges with Trump's new tariff policies impacting global trade.
Gold futures surge amid uncertainty over Trump tariffs on bullion bars.
Berkshire Hathaway reports a 4% drop in Q2 operating earnings as tariff impacts loom.
AB InBev shares fell 9% due to declining sales volumes in key markets like China and Brazil.
Logitech is progressing in relocating production from China to mitigate U.S. tariffs.
Nissan CEO Ivan Espinosa outlines a major savings plan to address the automaker's challenges.